AbbVie Inc. is 69.7x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($399.47 B vs $5.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MIRM | ABBV |
|---|---|---|
| Market cap | $5.73 B | $399.47 B |
| US-listed rank | #1294 | #28 |
| Revenue (latest FY) | $521.31M | $61.16B |
| Net income (latest FY) | -$23.36M | $4.23B |
| Net margin | -4.5% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 612 | 1,008 |
AbbVie Inc. is 69.7x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($399.47 B vs $5.73 B).
In their latest fiscal years, Mirum Pharmaceuticals, Inc. reported $521.31M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Mirum Pharmaceuticals, Inc. and AbbVie Inc., or browse the full rankings.